-
1
-
-
35748938818
-
Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: A case-control analysis
-
Zhang H, Sun X-F, Synnerstad I, et al. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis. Cancer J. 2007;13:233-237.
-
(2007)
Cancer J
, vol.13
, pp. 233-237
-
-
Zhang, H.1
Sun, X.-F.2
Synnerstad, I.3
-
2
-
-
25144462470
-
Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction
-
Lai HC, Lin WY, Lin YW, et al. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and gene-gene interaction. Gynecol Oncol. 2005;99:113-118.
-
(2005)
Gynecol Oncol
, vol.99
, pp. 113-118
-
-
Lai, H.C.1
Lin, W.Y.2
Lin, Y.W.3
-
3
-
-
20544473024
-
Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer
-
Zhang X, Miao X, Sun T, et al. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet. 2005;2:479-484.
-
(2005)
J Med Genet
, vol.2
, pp. 479-484
-
-
Zhang, X.1
Miao, X.2
Sun, T.3
-
4
-
-
34447100140
-
Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer
-
Zhang B, Sun T, Xue L, et al. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 2007;28:1067-1063.
-
(2007)
Carcinogenesis
, vol.28
, pp. 1067-1063
-
-
Zhang, B.1
Sun, T.2
Xue, L.3
-
5
-
-
3242670028
-
Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma
-
Jul 7;
-
Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst. 2004 Jul 7;96:1030-1036.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 1030-1036
-
-
Sun, T.1
Miao, X.2
Zhang, X.3
-
6
-
-
23844487130
-
Genetic polymorphisms of apop-tosis-associated genes FAS and FASL and risk of colorectal cancer
-
in Chinese
-
Yang S, Miao XP, Zhang XM, et al. Genetic polymorphisms of apop-tosis-associated genes FAS and FASL and risk of colorectal cancer. Zhonghua Yi Xue Za Zhi. 2005;85:2132-2135 (in Chinese).
-
(2005)
Zhonghua Yi Xue Za Zhi
, vol.85
, pp. 2132-2135
-
-
Yang, S.1
Miao, X.P.2
Zhang, X.M.3
-
7
-
-
33744956175
-
ING3 promotes UV-induced apoptosis via Fas/ caspase-8 pathway in melanoma cells
-
Elyassaki W, Wu S. ING3 promotes UV-induced apoptosis via Fas/ caspase-8 pathway in melanoma cells. J Biol Chem. 2006;281:11887-11893.
-
(2006)
J Biol Chem
, vol.281
, pp. 11887-11893
-
-
Elyassaki, W.1
Wu, S.2
-
8
-
-
0034660614
-
p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression
-
Ivanov VN, Ronai Z. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression. Oncogene. 2000;19:3003-3012.
-
(2000)
Oncogene
, vol.19
, pp. 3003-3012
-
-
Ivanov, V.N.1
Ronai, Z.2
-
9
-
-
0036052722
-
Evaluation of soluble Fas ligand as a serological marker for melanoma
-
Melzani G, Bugari G, Parrinello G, et al. Evaluation of soluble Fas ligand as a serological marker for melanoma. Dermatology. 2002;205: 111-115.
-
(2002)
Dermatology
, vol.205
, pp. 111-115
-
-
Melzani, G.1
Bugari, G.2
Parrinello, G.3
-
10
-
-
33748573355
-
Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival
-
Neuber K. Eidam B. Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival. Onkologie. 2006;29:361-365.
-
(2006)
Onkologie
, vol.29
, pp. 361-365
-
-
Neuber, K.1
Eidam, B.2
-
11
-
-
33645074700
-
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma
-
Li C, Larson D, Zhang Z, Liu Z, et al. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics. 2006;16:253-263.
-
(2006)
Pharmacogenet Genomics
, vol.16
, pp. 253-263
-
-
Li, C.1
Larson, D.2
Zhang, Z.3
Liu, Z.4
-
12
-
-
33750309227
-
Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population
-
Park SH, Choi JEm Kim EJ, et al. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. Lung Cancer. 2006;54:303-308.
-
(2006)
Lung Cancer
, vol.54
, pp. 303-308
-
-
Park, S.H.1
Choi, J.E.2
Kim, E.J.3
-
13
-
-
25844485937
-
FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer
-
Sun T, Zhou Y, Li H, et al. FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med. 2005;202:967-974.
-
(2005)
J Exp Med
, vol.202
, pp. 967-974
-
-
Sun, T.1
Zhou, Y.2
Li, H.3
-
14
-
-
0035999095
-
Frequent downregulation of Fas (CD95) expression and function in melanoma: Frequent downregulation of Fas (CD95) expression and function in melanoma
-
Bullani RR, Wehrli P, Viard-Leveugle I. Frequent downregulation of Fas (CD95) expression and function in melanoma: frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res. 2002;12:263-270.
-
(2002)
Melanoma Res
, vol.12
, pp. 263-270
-
-
Bullani, R.R.1
Wehrli, P.2
Viard-Leveugle, I.3
-
15
-
-
0036379395
-
Regulation of Fas-mediated apoptosis by N-ras in melanoma
-
Urquhart JL, Meech SJ, Marr DG, et al. Regulation of Fas-mediated apoptosis by N-ras in melanoma. J Invest Dermatol. 2002;119:556-561.
-
(2002)
J Invest Dermatol
, vol.119
, pp. 556-561
-
-
Urquhart, J.L.1
Meech, S.J.2
Marr, D.G.3
-
16
-
-
27644509111
-
Experimental therapy using interferonγ and anti-Fas antibody against oral malignant melanoma cells
-
Kamei T, Inui M, Nakase M, et al. Experimental therapy using interferonγ and anti-Fas antibody against oral malignant melanoma cells. Melanoma Res. 2005;15:393-400.
-
(2005)
Melanoma Res
, vol.15
, pp. 393-400
-
-
Kamei, T.1
Inui, M.2
Nakase, M.3
-
17
-
-
4344653705
-
Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice
-
Hall CL, Yao M, Hill LL, et al. Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice. Clin Exp Metastasis. 2004;21:251-256.
-
(2004)
Clin Exp Metastasis
, vol.21
, pp. 251-256
-
-
Hall, C.L.1
Yao, M.2
Hill, L.L.3
-
18
-
-
0347948596
-
CD95/Fas signaling in human melanoma cells: Conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants
-
Eberle J, Fecker LF, Hossini AM, et al. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Oncogene. 2003;22:9131-9141.
-
(2003)
Oncogene
, vol.22
, pp. 9131-9141
-
-
Eberle, J.1
Fecker, L.F.2
Hossini, A.M.3
-
19
-
-
11944251186
-
Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression
-
Fecker LF, Geilen CC, Hossini AM, et al. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression. J Invest Dermatol. 2005;124:221-228.
-
(2005)
J Invest Dermatol
, vol.124
, pp. 221-228
-
-
Fecker, L.F.1
Geilen, C.C.2
Hossini, A.M.3
|